Deutsche Cannabis ROA 2024

Deutsche Cannabis Aktienanalyse

What does Deutsche Cannabis do?

The German Cannabis AG is a rising company that specializes in the production and sale of medical cannabis. The company was founded in 2018 and is headquartered in Frankfurt am Main. The history of the German Cannabis AG began when a group of investors came together to invest in the growing market for medical cannabis. They recognized the potential that cannabis has as a medical product and the growing demand for high-quality cannabis. The founders of the company made it their mission to breed the best hemp varieties and extract the active ingredients in order to deliver the highest possible quality to their customers. The business model of the German Cannabis AG is based on growing and distributing medical cannabis. The company has its own plantation in Portugal, where it grows cannabis in modern greenhouses. The cultivation area is currently around 30 hectares and is planned to be expanded in the future. The company is committed to meeting the highest quality standards and therefore relies on state-of-the-art technologies and processes. For example, only organic-certified seeds are used to ensure optimal quality and purity of the end product. The German Cannabis AG offers various divisions to meet the different needs of customers. These divisions include not only medical cannabis but also CBD products, cosmetics, and dietary supplements. In the medical cannabis division, the company seeks to provide doctors and patients with high-quality and reliable products. The individual needs and specific requirements are the main focus. The company produces various products such as oils, capsules, flowers, or extracts that are tailored to the needs of patients. These products are sold exclusively to pharmacies and are available by prescription only. The CBD products division includes oils, cosmetics, and dietary supplements based on cannabidiol (CBD). These products are legal and can be purchased online or in specialty stores without a prescription. The company also places great emphasis on quality and reliability in this division and conducts intensive research and development. The cosmetics division includes various products such as creams, ointments, and balms based on medical cannabis. These are specifically offered for the treatment of skin problems such as eczema, psoriasis, or skin inflammation. Natural ingredients are used, and synthetic products are avoided. The dietary supplements division is characterized by high-quality products such as capsules, powders, or oils enriched with medical cannabis. These products support the immune system, digestion, and overall vitality of the body. In summary, the German Cannabis AG is a rising company specializing in the production and sale of medical cannabis and related products. Quality and reliability are the focus, and intensive investment is made in research and development. The different divisions offer customers a wide range of products that are individually tailored to their needs. Deutsche Cannabis ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Deutsche Cannabis's Return on Assets (ROA)

Deutsche Cannabis's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Deutsche Cannabis's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Deutsche Cannabis's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Deutsche Cannabis’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Deutsche Cannabis stock

What is the Return on Assets (ROA) of Deutsche Cannabis this year?

The Return on Assets (ROA) of Deutsche Cannabis is 0 undefined this year.

What was the ROA of Deutsche Cannabis compared to the previous year?

The ROA of Deutsche Cannabis has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Deutsche Cannabis?

A high ROA is advantageous for investors of Deutsche Cannabis, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Deutsche Cannabis?

A low ROA can be unfavorable for investors of Deutsche Cannabis as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Deutsche Cannabis affect the company?

An increase in ROA of Deutsche Cannabis can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Deutsche Cannabis impact the company?

A reduction in the ROA of Deutsche Cannabis can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Deutsche Cannabis?

Some factors that can influence the ROA of Deutsche Cannabis include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Deutsche Cannabis important for investors?

The ROA of Deutsche Cannabis is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Deutsche Cannabis take to improve ROA?

To improve ROA, Deutsche Cannabis can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Deutsche Cannabis pay?

Over the past 12 months, Deutsche Cannabis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Deutsche Cannabis is expected to pay a dividend of 0 EUR.

What is the dividend yield of Deutsche Cannabis?

The current dividend yield of Deutsche Cannabis is .

When does Deutsche Cannabis pay dividends?

Deutsche Cannabis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Deutsche Cannabis?

Deutsche Cannabis paid dividends every year for the past 0 years.

What is the dividend of Deutsche Cannabis?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Deutsche Cannabis located?

Deutsche Cannabis is assigned to the 'Communication' sector.

Wann musste ich die Aktien von Deutsche Cannabis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Deutsche Cannabis from 9/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Deutsche Cannabis pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Deutsche Cannabis in the year 2023?

In the year 2023, Deutsche Cannabis distributed 0 EUR as dividends.

In which currency does Deutsche Cannabis pay out the dividend?

The dividends of Deutsche Cannabis are distributed in EUR.